-
Mashup Score: 0A Prayer for a More Equitable Future - 4 year(s) ago
Russell J. Ledet, PhD, discusses being a Black man in the field of oncology.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0A Prayer for a More Equitable Future - 4 year(s) ago
Russell J. Ledet, PhD, discusses being a Black man in the field of oncology.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0PLCOm2012 Risk Prediction Model Is Highly Sensitive in Identifying African American Ever-Smokers With Lung Cancer - 4 year(s) ago
The PLCOm2012 risk prediction model is a preferable lung cancer screening method for identifying African American ever-smokers over the current United States Preventive Services Task Force lung cancer screening eligibility criteria, which may help to overcome racial disparities.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Data from a subgroup analysis of the phase 2 GRIFFIN study demonstrated that adding daratumumab to lenalidomide, bortezomib, and dexamethasone improved depth of response, stringent complete response, and minimal residual disease negativity, in Black patients with newly diagnosed multiple myeloma.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0PLCOm2012 Risk Prediction Model Is Highly Sensitive in Identifying African American Ever-Smokers With Lung Cancer - 4 year(s) ago
The PLCOm2012 risk prediction model is a preferable lung cancer screening method for identifying African American ever-smokers over the current United States Preventive Services Task Force lung cancer screening eligibility criteria, which may help to overcome racial disparities.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Data from a subgroup analysis of the phase 2 GRIFFIN study demonstrated that adding daratumumab to lenalidomide, bortezomib, and dexamethasone improved depth of response, stringent complete response, and minimal residual disease negativity, in Black patients with newly diagnosed multiple myeloma.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Gutierrez Provides Insight on Bridging Gaps in Cancer Care - 4 year(s) ago
In our exclusive interview, Rodolfo Gutierrez, MD, discusses the issues that surround access to care and clinical outcomes with Hispanic patients, efforts The Angeles Clinic has spearheaded to bridge this gap in care, and the importance of patient and provider education and awareness.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Findings have shown that patients with cancer are at an increased risk of developing severe illness due to coronavirus disease 2019.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Experts Call for Increased Awareness of Existing Racial Disparities in Cancer Care and Survival - 4 year(s) ago
Despite the numerous reports detailing racial differences in cancer outcomes and care over the years, the reasons underlying these disparities continue to be under deep exploration.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Experts Call for Increased Awareness of Existing Racial Disparities in Cancer Care and Survival - 4 year(s) ago
Despite the numerous reports detailing racial differences in cancer outcomes and care over the years, the reasons underlying these disparities continue to be under deep exploration.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Medical institutions are “considering” the idea of evaluating their role in health disparities that have been exacerbated by the #COVID-19 pandemic but were here long before that. #raceincancer #raceinoncology https://t.co/92WkRo69qk